{"title":"肝细胞线粒体DNA通过Stim1/ orai1诱导的三氯乙烯致敏小鼠足细胞损伤激活储存操作的Ca2+进入:肝脏和肾脏串扰的新见解。","authors":"Luo-lun Dong , Xue-qian Jia , Hai-bo Xie , Li-fu Zhu , Peng-cheng Zhou , Rui-xuan Cheng , Chun-lin Cao , Qi-xing Zhu , Jia-xiang Zhang","doi":"10.1016/j.taap.2025.117465","DOIUrl":null,"url":null,"abstract":"<div><div>Previous clinical case studies revealed that patients with severe liver damage often develop kidney damage in occupational medicamentose-like dermatitis due to trichloroethylene (OMDT). However, the mechanism of this crosstalk is unknown. In this study, we extracted hepatocyte mtDNA from TCE-sensitized positive mice and co-treated it with a mouse podocyte line, MPC5. The expression of the stromal interaction molecule 1 (Stim1) and calcium release-activated calcium channel protein 1 (Orai1) proteins did not change significantly with or without interference with the Stimulator of interferon gene (STING) protein in hepatocyte mtDNA pretreated MPC5 cells. Subsequently, siRNA interference treatment of Stim1 and Orai1, respectively, was found to significantly ameliorate the damage to podocytes. Moreover, lentiviral transfection for overexpression of the key protein Orai1 was carried out, and the expression of inflammatory factors was significantly elevated. In animal experiments, the SOCE inhibitor YM-58483 was used to treat TCE-sensitized mice, and the administration of YM-58483 alleviated the reduction in the expression of podocyte injury proteins. In summary, this study explored the role of hepatocyte mtDNA-mediated podocyte injury in Ca<sup>2+</sup> signaling pathway activation and immune kidney injury in TCE sensitization-positive mice. We found that hepatocyte mtDNA enhances SOCE by increasing the interaction between Orai1 and Stim1 and that SOCE activation mediated by hepatocyte mtDNA processing regulates the secretion of inflammatory factors by podocytes. SOCE inhibitors reversed this phenomenon and mitigated immune kidney damage caused by TCE sensitization. This study provides new insight into the mechanisms of renal damage in liver and kidney crosstalk induced by TCE sensitization.</div></div>","PeriodicalId":23174,"journal":{"name":"Toxicology and applied pharmacology","volume":"503 ","pages":"Article 117465"},"PeriodicalIF":3.3000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hepatocyte mitochondrial DNA activated store-operated Ca2+ entry via Stim1/Orai1-induced podocyte injury in trichloroethylene sensitized mice: A new insight in liver and kidney crosstalk\",\"authors\":\"Luo-lun Dong , Xue-qian Jia , Hai-bo Xie , Li-fu Zhu , Peng-cheng Zhou , Rui-xuan Cheng , Chun-lin Cao , Qi-xing Zhu , Jia-xiang Zhang\",\"doi\":\"10.1016/j.taap.2025.117465\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Previous clinical case studies revealed that patients with severe liver damage often develop kidney damage in occupational medicamentose-like dermatitis due to trichloroethylene (OMDT). However, the mechanism of this crosstalk is unknown. In this study, we extracted hepatocyte mtDNA from TCE-sensitized positive mice and co-treated it with a mouse podocyte line, MPC5. The expression of the stromal interaction molecule 1 (Stim1) and calcium release-activated calcium channel protein 1 (Orai1) proteins did not change significantly with or without interference with the Stimulator of interferon gene (STING) protein in hepatocyte mtDNA pretreated MPC5 cells. Subsequently, siRNA interference treatment of Stim1 and Orai1, respectively, was found to significantly ameliorate the damage to podocytes. Moreover, lentiviral transfection for overexpression of the key protein Orai1 was carried out, and the expression of inflammatory factors was significantly elevated. In animal experiments, the SOCE inhibitor YM-58483 was used to treat TCE-sensitized mice, and the administration of YM-58483 alleviated the reduction in the expression of podocyte injury proteins. In summary, this study explored the role of hepatocyte mtDNA-mediated podocyte injury in Ca<sup>2+</sup> signaling pathway activation and immune kidney injury in TCE sensitization-positive mice. We found that hepatocyte mtDNA enhances SOCE by increasing the interaction between Orai1 and Stim1 and that SOCE activation mediated by hepatocyte mtDNA processing regulates the secretion of inflammatory factors by podocytes. SOCE inhibitors reversed this phenomenon and mitigated immune kidney damage caused by TCE sensitization. This study provides new insight into the mechanisms of renal damage in liver and kidney crosstalk induced by TCE sensitization.</div></div>\",\"PeriodicalId\":23174,\"journal\":{\"name\":\"Toxicology and applied pharmacology\",\"volume\":\"503 \",\"pages\":\"Article 117465\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Toxicology and applied pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0041008X25002418\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology and applied pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041008X25002418","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Hepatocyte mitochondrial DNA activated store-operated Ca2+ entry via Stim1/Orai1-induced podocyte injury in trichloroethylene sensitized mice: A new insight in liver and kidney crosstalk
Previous clinical case studies revealed that patients with severe liver damage often develop kidney damage in occupational medicamentose-like dermatitis due to trichloroethylene (OMDT). However, the mechanism of this crosstalk is unknown. In this study, we extracted hepatocyte mtDNA from TCE-sensitized positive mice and co-treated it with a mouse podocyte line, MPC5. The expression of the stromal interaction molecule 1 (Stim1) and calcium release-activated calcium channel protein 1 (Orai1) proteins did not change significantly with or without interference with the Stimulator of interferon gene (STING) protein in hepatocyte mtDNA pretreated MPC5 cells. Subsequently, siRNA interference treatment of Stim1 and Orai1, respectively, was found to significantly ameliorate the damage to podocytes. Moreover, lentiviral transfection for overexpression of the key protein Orai1 was carried out, and the expression of inflammatory factors was significantly elevated. In animal experiments, the SOCE inhibitor YM-58483 was used to treat TCE-sensitized mice, and the administration of YM-58483 alleviated the reduction in the expression of podocyte injury proteins. In summary, this study explored the role of hepatocyte mtDNA-mediated podocyte injury in Ca2+ signaling pathway activation and immune kidney injury in TCE sensitization-positive mice. We found that hepatocyte mtDNA enhances SOCE by increasing the interaction between Orai1 and Stim1 and that SOCE activation mediated by hepatocyte mtDNA processing regulates the secretion of inflammatory factors by podocytes. SOCE inhibitors reversed this phenomenon and mitigated immune kidney damage caused by TCE sensitization. This study provides new insight into the mechanisms of renal damage in liver and kidney crosstalk induced by TCE sensitization.
期刊介绍:
Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.
Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.
Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.